Tubulins as Therapeutic Targets in Cancer: from Bench to Bedside

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|19|2778-2792

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.19, 2012-06, pp. : 2778-2792

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regorafenib: from bench to bedside in colorectal cancer

By Shahda Safi   Saif Muhammad Wasif  

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 3, 2013-05 ,pp. : 243-248

Informa Healthcare

Access to resources Recommend Favorite

Vascular NO: from bench to bedside

By Tsikas Dimitrios  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. : 3-3

Springer Publishing Company

Access to resources Recommend Favorite

CETUXIMAB: From Bench to Bedside

By  

Current Cancer Drug Targets, Vol. 10, Iss. 1, 2010-01 ,pp. : 80-95

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Cancer Biomarkers from Bench to Bedside)

By  

Current Cancer Drug Targets, Vol. 15, Iss. 8, 2015-01 ,pp. : 642-642

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside Translation

By  

Current Drug Targets, Vol. 13, Iss. 6, 2012-05 ,pp. : 744-752

Bentham Science Publishers

Access to resources Recommend Favorite